نتایج جستجو برای: salvage chemotherapy

تعداد نتایج: 125989  

Journal: :The American journal of the medical sciences 2005
Jen-Tsun Lin Wang Wei-Shu Chueh-Chuan Yen Jin-Huang Liu Po-Min Chen Tzeon-Jye Chiou

BACKGROUND This study was performed to investigate the clinical factors, tumor characteristics, treatment approach, and prognosis of patients with Stage IV thymic carcinoma (WHO type C). METHODS The records of 20 patients with histologically confirmed thymic carcinoma treated between 1988 and 2002 at the Division of Oncology at Taipei Veterans General Hospital were reviewed. RESULTS Therapy...

Journal: :Japanese journal of clinical oncology 2002
Tsai-Shen Yang Jeng-Yi Wang Reiping Tang Kuan-Cheng Hsu Jen-Shi Chen

BACKGROUND The purpose of this study was to determine the efficacy and toxicity of uracil/ftorafur (UFT) plus oral leucovorin (LV) as first-line chemotherapy for patients with metastatic colorectal cancer and salvage chemotherapy with weekly high-dose 5-fluorouracil (5-FU)/LV 24 h infusion. METHODS Adult patients with no prior chemotherapy for metastatic diseases were enrolled to receive oral...

2018
Binbin Hu Xiaojuan Zhou Yongmei Liu Qian Li Mengmeng Xiang Bingwen Zou Feng Peng Meijuan Huang Youling Gong Jiang Zhu Yongsheng Wang Li Ren Yong Xu Yan Zhang Yanying Li Min Yu Jianxin Xue Lei Deng Jin Wang Zhenyu Ding You Lu

The addition of bevacizumab to chemotherapy has demonstrated efficacy as a first-line treatment for non-small cell lung cancer (NSCLC). Whether this combination is effective as a salvage treatment for patients with NSCLC remains unclear. The present retrospective study was designed to compare the efficacy and safety of chemotherapy plus bevacizumab with chemotherapy alone as a third-line, or co...

Journal: :Cancer journal 2009
Fahd Quddus James O Armitage

Hodgkin's lymphoma (HL) is a clonal lymphoid malignancy that affects over 7000 patients in the United States annually. The disease remains one of the great success stories in the recent history of cancer treatment. More than 80% of HL patients will be expected to be long-term survivors because of recent advances in radiation therapy and combined chemotherapy. However, for the subset of patients...

Journal: :Blood 1999
Slobodan Stanisic Matt Kalaycio

Refractory and relapsed disease occurs in most acute myelogenous leukemia patients. Salvage chemotherapy offers a 30-70% chance of a second complete remission. Unfortunately, this second remission is usually short lived and salvage chemotherapy is rarely curative. Allogeneic bone marrow transplant, either human leukocyte antigen (HLA)-sibling matched or matched unrelated donor, is the only trea...

2010
Joo Young Shin Jeong Hun Kim Young Suk Yu Sang In Khwarg Ho Kyung Choung Hee Young Shin Hyo Seop Ahn

PURPOSE To evaluate the efficacy of primary chemotherapy combined with local therapy in the treatment of retinoblastomas not treatable with a single therapeutic method. METHODS We performed a retrospective chart review of 227 patients diagnosed with retinoblastoma. Sixty-five eyes in 52 patients had tumors not treatable with a single therapeutic method and received primary chemotherapy combin...

Journal: :Japanese journal of clinical oncology 2003
Jun Miyazaki Koji Kawai Hitoshi Hayashi Mizuki Onozawa Sadamu Tsukamoto Naoto Miyanaga Shiro Hinotsu Toru Shimazui Hideyuki Akaza

BACKGROUND Combination chemotherapy of methotrexate, actinomycin D and cisplatin (MAP) is reported to be effective against gestational choriocarcinoma. METHODS Eight patients with metastatic testicular cancer who had elevated beta-hCG were treated with MAP. They included three refractory cases and two relapsed cases. An additional three patients received MAP as part of the induction therapy. ...

Journal: :Anticancer research 2012
Motohiro Tamiya Akihiro Tamiya Keiko Nakao Kazuhiro Asami Kyoichi Okishio Morita Satomu Takayuki Shiroyama Naoko Morishita Hidekazu Suzuki Shinji Sasada Norio Okamoto Tomoya Kawaguchi Masashi Kobayashi Shinji Atagi Tomonori Hirashima Ichiro Kawase

BACKGROUND Salvage chemotherapy using carboplatin (C), paclitaxel (P), and bevacizumab (BEV) for patients with pre-treated, advanced non-squamous non-small cell lung cancer (NSCLC) has not yet been reported. PATIENT AND METHODS Medical records of patients with non-squamous NSCLC who received CP plus BEV between November 2009 and September 2011 and experienced progression after at least one pl...

2012
Burcu Türker Burak Uz Metin Işık Özlen Bektaş Haluk Demiroğlu Nilgün Sayınalp Aysegül Üner Osman İlhami Özcebe

UNLABELLED Nasal-type natural killer (NK)/T-cell lymphoma (NKTL) is a rare disease strongly associated with Epstein-Barr virus and is often localized to the upper aerodigestive tract at presentation. Extranodal NKTL may involve any extranodal site and disease beyond the nasal cavity is highly aggressive, with short survival time and poor response to therapy. Herein we present a 57-year-old male...

2011
Karin U. Sorenmo Erika Krick Christina M. Coughlin Beth Overley Thomas P. Gregor Robert H. Vonderheide Nicola J. Mason

Cell-based active immunotherapy for cancer is a promising novel strategy, with the first dendritic cell (DC) vaccine achieving regulatory approval for clinical use last year. Manufacturing remains arduous, especially for DC vaccines, and the prospect of using cell-based immunotherapy in the adjuvant setting or in combination with chemotherapy remains largely untested. Here, we used a comparativ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید